NCT03040128View on ClinicalTrials.gov

Use of Minocycline in Intracerebral Hemorrhage

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

June 27, 2013

Primary Completion Date

November 30, 2016

Study Completion Date

November 30, 2016

Conditions
Intracerebral Hemorrhage
Interventions
DRUG

Minocycline

high-dose, intravenous minocycline

OTHER

normal saline infusion

All Listed Sponsors
collaborator

University of Southern California

OTHER

lead

University of Tennessee

OTHER

NCT03040128 - Use of Minocycline in Intracerebral Hemorrhage | Biotech Hunter | Biotech Hunter